Key Concepts & Self-Assessment18 Key Facts
Review key What Is an Allosteric Enzyme and How Can Cells Control Enzyme Activity exam facts and rate your mastery to track revision.
Progress: 0/18 Rated 0 Mastered 0 Review Later
#1
Allosteric enzymes feature regulatory binding sites spatially segregated from catalytic active sites, enabling distinct effector molecules to alter enzyme catalytic velocity through long-range conformational adjustments.
#2
Jacques Monod, Jean-Pierre Changeux, and Francois Jacob formulated the allostery concept between 1961 and 1965, explaining non-competitive feedback interactions in bacterial amino acid biosynthesis pathways.
#3
Sigmoidal velocity-substrate curves distinguish allosteric enzymes from standard hyperbolic Michaelis-Menten kinetics, demonstrating cooperative binding where initial substrate interaction enhances subsequent substrate binding affinity across subunits.
#4
The Monod-Wyman-Changeux concerted model posits that multi-subunit enzymes exist in equilibrium between a low-affinity tense state and a high-affinity relaxed state while preserving molecular conformational symmetry.
#5
The Koshland-Nemethy-Filmer sequential model proposes that ligand binding triggers localized conformational adjustments in individual subunits, which subsequently alter adjacent subunit affinities through progressive induced-fit structural rearrangements.
#6
Positive cooperativity yields a Hill coefficient greater than one, reflecting steep acceleration in catalytic velocity over narrow substrate concentration ranges to provide precise metabolic control.
#7
Aspartate transcarbamoylase catalyzes the initial committed reaction of pyrimidine nucleotide synthesis, converting carbamoyl phosphate and L-aspartate into N-carbamoyl-L-aspartate through tightly controlled multi-subunit allosteric mechanics.
#8
Cytidine triphosphate functions as an allosteric inhibitor of aspartate transcarbamoylase, stabilizing the inactive tense state to prevent wasteful overproduction of downstream pyrimidine ribonucleotides.
#9
Adenosine triphosphate acts as an allosteric activator of aspartate transcarbamoylase, shifting the conformational equilibrium toward the active relaxed state to balance purine and pyrimidine pools.
#10
Structural studies reveal that aspartate transcarbamoylase comprises twelve polypeptide chains organized into two catalytic trimers and three regulatory dimers that rotate during allosteric state transitions.
#11
Phosphofructokinase-1 operates as the primary rate-limiting regulatory enzyme of glycolysis, converting fructose-6-phosphate and ATP into fructose-1,6-bisphosphate and ADP within the cellular cytosol.
#12
High intracellular ATP concentrations allosterically inhibit phosphofructokinase-1 by binding to distinct low-affinity regulatory sites, reducing catalytic affinity for fructose-6-phosphate during energetic abundance.
#13
Fructose-2,6-bisphosphate functions as a potent allosteric activator of phosphofructokinase-1, overriding ATP inhibition and stimulating glycolytic carbon flux during hepatic feeding and insulin signaling.
#14
Homotropic allosteric interactions occur when the substrate itself functions as the allosteric effector, promoting cooperative conformational shifts among identical binding pockets across oligomeric subunits.
#15
Heterotropic allosteric interactions involve distinct non-substrate effector molecules that bind regulatory domains, modulating substrate affinity positively as activators or negatively as non-competitive inhibitors.
#16
Feedback end-product inhibition allows terminal pathway products to halt their own biosynthesis by allosterically deactivating early rate-limiting pathway enzymes without blocking downstream intermediate catalysts.
#17
Hemoglobin exhibits cooperative allosteric oxygen binding governed by quaternary structural transitions between deoxy-tense and oxy-relaxed states, functioning as an archetypal physiological model of allosteric regulation.
#18
Pharmacological drug development increasingly targets allosteric binding sites rather than conserved active sites, achieving higher receptor selectivity and fewer off-target toxicities across mammalian protein families.
Subject Specialist Commentary
Analytical perspective & practical exam advice from the Master10 academic board
Allosteric regulation represents an elegant evolutionary solution to the challenge of metabolic homeostasis, allowing cells to sense energetic and biosynthetic demands with extraordinary sensitivity. Classical Michaelis-Menten enzymes adjust velocity gradually in linear proportion to substrate fluctuations. In sharp contrast, allosteric enzymes function as molecular microprocessors that interpret chemical signals cooperatively. Consequently, minor changes in cellular metabolite pools trigger decisive shifts in pathway flux, safeguarding resources and maintaining systemic thermodynamic equilibrium.
Modern medicine actively exploits allosteric sites to design highly selective modulators that avoid the toxic non-specific effects of active-site competitors. Because catalytic pockets often share high sequence homology across related protein families, targeting variable allosteric clefts enables subtle, fine-tuned pharmacological control without completely extinguishing essential basal activity. For competitive examinations and biochemical mastery, remember the allosteric regulation paradigm through the acronym TRACS: Tense state low affinity, Relaxed state high affinity, Allosteric effector binding, Cooperative kinetics, and Sigmoidal velocity curves.
Related Knowledge Topics to Discover
Looking for more GK practice?
Explore 52,789+ questions across 65 General Knowledge categories.